ABCA1 and Stroke: We are the first to demonstrate that intracerebral supplementation of ApoE2, the downstream molecule of ABCA1 in brain, compensates for the neurological deficits of brain ABCA1 deficiency in both an experimental stroke model and cell cultures, at least partially by increasing brain ApoER2 and cholesterol uptake.